BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND CD274, PDL1, 29126, ENSG00000120217, PDCD1L1, PD-L1, MGC142296, PDCD1LG1, MGC142294, B7H1, Q9NZQ7, B7-H AND Diagnosis
50 results:

  • 1. [Expression of immune checkpoints pd-l1, CTLA4, LAG3 in the microenvironment of colon adenocarcinoma depending on MMR status].
    Naumov SS; Krakhmal NV; Tashireva LA; Vtorushin SV
    Arkh Patol; 2024; 86(2):6-13. PubMed ID: 38591901
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and FOXP3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Gastroesophageal Adenocarcinomas With Defective Mismatch Repair: Current Knowledge and Clinical Management.
    Strickland MR; Lander EM; Gibson MK; Ilson DH; Ajani JA; Klempner SJ
    J Natl Compr Canc Netw; 2024 Mar; 22(3):. PubMed ID: 38503041
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Identification of HSP90B1 in pan-cancer hallmarks to aid development of a potential therapeutic target.
    Huang X; Zhang W; Yang N; Zhang Y; Qin T; Ruan H; Zhang Y; Tian C; Mo X; Tang W; Liu J; Zhang B
    Mol Cancer; 2024 Jan; 23(1):19. PubMed ID: 38243263
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. The expression of UNC5D is abnormal in the early stage of colorectal tumors associated with its proliferation and migration.
    Shi LP; Zou C; Mao LJ; Chen TT; Xie T
    Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):199-213. PubMed ID: 38235871
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Multi-omics of the gut microbial ecosystem in patients with microsatellite-instability-high gastrointestinal cancer resistant to immunotherapy.
    Cheng S; Han Z; Dai D; Li F; Zhang X; Lu M; Lu Z; Wang X; Zhou J; Li J; Guo X; Song P; Qiu C; Shen W; Zhang Q; Zhu N; Wang X; Tan Y; Kou Y; Yin X; Shen L; Peng Z
    Cell Rep Med; 2024 Jan; 5(1):101355. PubMed ID: 38194971
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. PFKP is a prospective prognostic, diagnostic, immunological and drug sensitivity predictor across pan-cancer.
    Peng J; Li P; Li Y; Quan J; Yao Y; Duan J; Liu X; Li H; Yuan D; Wang X
    Sci Rep; 2023 Oct; 13(1):17399. PubMed ID: 37833332
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. CHSY1 promotes CD8
    Sun G; Zhao S; Fan Z; Wang Y; Liu H; Cao H; Sun G; Huang T; Cai H; Pan H; Rong D; Gao Y; Tang W
    J Exp Clin Cancer Res; 2023 Sep; 42(1):248. PubMed ID: 37749638
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
    Mishima S; Naito Y; Akagi K; Hayashi N; Hirasawa A; Hishiki T; Igarashi A; Ikeda M; Kadowaki S; Kajiyama H; Kato M; Kenmotsu H; Kodera Y; Komine K; Koyama T; Maeda O; Miyachi M; Nishihara H; Nishiyama H; Ohga S; Okamoto W; Oki E; Ono S; Sanada M; Sekine I; Takano T; Tao K; Terashima K; Tsuchihara K; Yatabe Y; Yoshino T; Baba E
    Int J Clin Oncol; 2023 Oct; 28(10):1237-1258. PubMed ID: 37599324
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Microsatellite Instability and Immune Response: From Microenvironment Features to Therapeutic Actionability-Lessons from colorectal cancer.
    Greco L; Rubbino F; Dal Buono A; Laghi L
    Genes (Basel); 2023 May; 14(6):. PubMed ID: 37372349
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Circular RNA hsa_circ_0064559 affects tumor cell growth and progression of colorectal cancer.
    Zhen Y; Sun G; Chen C; Li J; Xiao R; Xu Z
    World J Surg Oncol; 2023 Jun; 21(1):171. PubMed ID: 37280630
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Prognostic significances of pd-l1- and CTLA-4-positive T cells and positive correlations of immunosuppressive marker expression between cancer tissue and peripheral blood in patients with gastric cancer.
    Lee KH; Kim SJ; Woo JS; Lee SY; Jhun J; Moon J; Jung YJ; Cho ML; Song KY
    Front Immunol; 2023; 14():1138743. PubMed ID: 37153541
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Clinicopathological characteristics of gastric SMARCA4-deficient undifferentiated/rhabdoid carcinoma].
    Wu JY; Jiang K; Yan LJ; Yin LS; Huang XZ; Jia L; Sun Y
    Zhonghua Bing Li Xue Za Zhi; 2023 May; 52(5):447-453. PubMed ID: 37106285
    [No Abstract]    [Full Text] [Related]  

  • 14. Influence of location-dependent sex difference on pd-l1, MMR/MSI, and EGFR in colorectal carcinogenesis.
    Choi J; Kim N; Nam RH; Kim JW; Song CH; Na HY; Kang GH
    PLoS One; 2023; 18(2):e0282017. PubMed ID: 36802389
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deficient mismatch repair/microsatellite unstable colorectal cancer: diagnosis, prognosis and treatment.
    Taieb J; Svrcek M; Cohen R; Basile D; Tougeron D; Phelip JM
    Eur J Cancer; 2022 Nov; 175():136-157. PubMed ID: 36115290
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Microsatellite instability/mismatch repair deficiency and activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland: A case report.
    Yang G
    Medicine (Baltimore); 2022 Aug; 101(34):e30311. PubMed ID: 36042639
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Roles of circulating tumor DNA in PD-1/pd-l1 immune checkpoint Inhibitors: Current evidence and future directions.
    Liu Z; Han Y; Dang Q; Xu H; Zhang Y; Duo M; Lv J; Li H; Kong Y; Han X
    Int Immunopharmacol; 2022 Oct; 111():109173. PubMed ID: 35998502
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. pd-l1 Expression in colorectal Adenocarcinoma Is Associated With the Tumor Immune Microenvironment and Epithelial-Mesenchymal Transition.
    Secinti IE; Ozgur T; Dede I
    Am J Clin Pathol; 2022 Oct; 158(4):506-515. PubMed ID: 35938631
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Targeting the lncRNA FGD5-AS1/miR-497-5p/pd-l1 Axis Inhibits Malignant Phenotypes in Colon cancer (CC).
    Zhang L; Cai X; Dai Y; Chen Y; Yu J; Zhou Y
    Biomed Res Int; 2022; 2022():1133332. PubMed ID: 35845947
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Clinical, pathological genetics and intratumoral immune milieu of serrated adenocarcinoma of the colon.
    Yılmaz O; Crabbe A; Neyaz A; Pankaj A; Lee SH; Hosseini S; Rickelt S; Cerda S; Zhao Q; Leijsen L; Dineaux A; Shroff SG; Crotty R; Zhang ML; Yilmaz OH; Patil DT; Berger D; Deshpande V
    Histopathology; 2022 Sep; 81(3):380-388. PubMed ID: 35789111
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.